Rosetta Inpharmatics LLC
Records under this name other than patents Rosetta Inpharmatics LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Rosetta Inpharmatics LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,962,316 | Method of Designing Sirnas for Gene Silencing Formerly held In force · High confidence | In force | High confidence | |
| US 8,378,088 | Compositions Comprising MIR34 Therapeutic Agents for Treating Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 8,609,830 | Methods and compositions for rna interference Formerly held In force · High confidence | In force | High confidence | |
| US 8,399,248 | Methods of Using MIR34 as a Biomarker for TP53 Functional Status Formerly held In force · High confidence | In force | High confidence | |
| US 9,200,275 | Methods and Compositions for Regulating Cell Cycle Progression Formerly held In force · High confidence | In force | High confidence | |
| US 8,843,356 | Computer systems and methods for associating genes with traits using cross species data Formerly held Lapsed on the fee record Ended Sep 23, 2026 · High confidence | Lapsed on the fee record | Ended Sep 23, 2026 | High confidence |
| US 7,729,864 | Computer Systems and Methods for Identifying Surrogate Markers Formerly held Term ended Term ended Jul 13, 2026 · High confidence | Term ended | Term ended Jul 13, 2026 | High confidence |
| US 8,761,465 | Centroid Processing Formerly held Lapsed on the fee record Ended Jun 24, 2026 · High confidence | Lapsed on the fee record | Ended Jun 24, 2026 | High confidence |
| US 8,071,306 | Methods for Quantitating Small RNA Molecules Formerly held Term ended Term ended May 17, 2026 · High confidence | Term ended | Term ended May 17, 2026 | High confidence |
| US 7,653,491 | Computer Systems and Methods for Subdividing a Complex Disease into Component Diseases Formerly held Term ended Term ended Oct 22, 2025 · High confidence | Term ended | Term ended Oct 22, 2025 | High confidence |